SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Elisabeth of Austria

PatientElisabeth of Austria
Date of birth1969-12-24
IdentifiersMRN HR-NI030-SYN; SSN (made up) 000-30-5817
Document date2026-06-30
AuthorAdelheid Marchetti-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Twenty-one-week review: weight, mood, the gastroenteritis, and care while travelling. [S]

History of Present Illness

Empress Elisabeth returns five weeks after a gastroenteritis. The diarrhea settled within three days and she was back on her meal plan within the week, with no restriction afterwards. She did not have the blood test planned for two to three days after that visit, because she left to travel two days later and no laboratory was arranged. She has taken sertraline 50 mg daily. Her mood is better; she has had no thoughts of death. She walks about an hour a day and would like to return to some gymnastics. She leaves in a week to travel for six weeks, by sea and to her villa on the island, and asks how her care will continue while she is away. [S]

ElementDetail
GastroenteritisSettled within three days; back on the meal plan
Missed testElectrolytes planned two to three days after the sick visit not drawn
MoodBetter; PHQ-9 7; no thoughts of death
TravelLeaves in a week for six weeks

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy good; no longer cold
GastrointestinalNegativeNo diarrhea or vomiting
CardiovascularNegativeNo swelling, palpitations or dizziness
PsychiatricNegativeMood better; no thoughts of death

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal planonce daily for 14 daysOral route2026-02-03 to 2026-02-17completedS
Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth dailyonce dailyOral route2026-02-03activeS
Potassium chloride 20 mEq extended-release tablet, one by mouth daily with food for three daysonce daily for three daysOral route2026-05-26 to 2026-05-28completedS
Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weekstwice daily with mealsOral route2026-02-10 to 2026-03-03completedS
Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a mealonce daily with a mealOral route2026-03-03activeS
Sertraline 25 mg tablet, one by mouth each morning for two weeksonce daily in the morningOral route2026-03-03 to 2026-03-17completedS
Sertraline 50 mg tablet, one by mouth each morningonce daily in the morningOral route2026-03-17activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-30Body height172cmS
2026-06-30Body weight54kgS
2026-06-30Body mass index (BMI) [Ratio]18.3kg/m2S
2026-06-30Systolic blood pressure106mm[Hg]S
2026-06-30Diastolic blood pressure68mm[Hg]S
2026-06-30Heart rate62/minS
2026-06-30Respiratory rate14/minS
2026-06-30Body temperature36.5CelS
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-30Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-06-30Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-06-30Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.2 mg/dLNormalS
2026-06-30Phosphate [Mass/volume] in Serum or Plasma3.6mg/dL2.5-4.5 mg/dLNormalS
2026-06-3025-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30-100 ng/mLNormalS
2026-06-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S

Physical Exam

Vital signs recorded on 2026-06-30; see the Vital Signs section. [S]

SystemFinding
GeneralSlim; weight 54.0 kg, BMI 18.3; temperature 36.5 C
CardiovascularSeated blood pressure 106/68, pulse 62; no orthostatic change; no edema
PsychiatricBrighter; reactive affect; no intent or plan to harm herself

Problems

ProblemClinical statusVerificationCodeProvenance
Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requestedresolvedconfirmed R63.4S — Synthetic presenting problem anchored to her documented restrictive eating, low weight and swelling; superseded by the diagnosis at the consultation.
Anorexia nervosa, restricting type, moderate (DSM-5-TR), with compulsive exercise and frequent self-weighing, beginning in early adulthood; complicated at diagnosis by sinus bradycardia, orthostatic dizziness, ankle edema, mild anemia and leukopenia, low glucose, raised ALT and low phosphate after refeeding beganactiveconfirmed F50.011S — Synthetic modern diagnosis made at the consultation, linked to her documented restrictive eating and exercise and to the retrospective diagnosis of anorexia nervosa (R).
Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intakeactiveconfirmed F33.1S — Synthetic modern diagnosis linked to her documented mourning and ever-deepening depressions; not a claim that she was so diagnosed.
Acute viral gastroenteritis, caught from a member of her travelling party, with mild dehydration, orthostatic hypotension and mild hypokalemia; no purging behavior; managed with oral rehydration and potassium; resolvedresolvedconfirmed A08.4S — Synthetic acute problem; not a historical claim.
Low bone mass (osteopenia) of the lumbar spine and hip after decades of low weight: lumbar spine T-score -2.1, femoral neck T-score -1.8; FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture; no fracturesactiveconfirmed M85.80S — Synthetic modern finding on DXA; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationWeight and BMI (open weighing in the consulting room)Weekly at first, then every visitCompleted today54.0 kg, BMI 18.3; up 6.6 kg since intake
ExaminationOrthostatic pulse and blood pressure, and temperatureEvery visitCompleted todayPulse 62, blood pressure 106/68, no orthostatic change; temperature 36.5 C
LaboratorySodium, potassium, phosphate, magnesium and glucoseBaseline; three to four days after nutrition starts; weekly for the first weeks; then at each visit while underweightCompleted todaySodium 138, potassium 4.1 mmol/L, phosphate 3.6 mg/dL, magnesium 2.0 mg/dL. Protocol deviation: the electrolytes and magnesium planned for two to three days after the sick visit, when potassium was 3.3 mmol/L, were not drawn, because she left to travel and no laboratory had been arranged. No harm resulted: she took the three days of potassium, the illness settled, and today's results are normal. Corrective action: when a recheck is needed before she travels, it is drawn before she leaves or booked at a laboratory where she will be
Laboratory25-hydroxyvitamin D after repletionAbout three months after starting, then yearlyCompleted today34 ng/mL on 2,000 IU daily
ExaminationRefeeding edema and signs of heart failureEvery visitCompleted todayNo edema
Self-managementExercise and compulsive activityEvery visitCompleted todayAbout an hour of walking a day; graded return agreed: stretching twice a week, walks up to 90 minutes
Self-managementMultidisciplinary treatment: CBT-E attendance, dietitian, psychiatryWeekly therapy; dietitian every two weeksCompleted todayWeekly CBT-E and dietitian attended; video sessions arranged for the journey
SurveyPHQ-9At least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today7, a 56 percent fall from 16
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visitCompleted todayNo thoughts of death since the last visit; PHQ-9 item 9 scored 0. Safety plan updated for travel
Medication safetyAdherence and adverse-effect reviewEvery visitCompleted todayNo missed doses, including during the gastroenteritis; no side effects
ImagingDXA of the spine and hipEvery two yearsUp to dateLow bone mass four months ago; repeat in two years

Goal progress:

Immunizations given today: Recombinant zoster vaccine, dose 2 of 2 [S]

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults (position paper) (2022); Eating Disorders: A Guide to Medical Care (AED Medical Care Standards Guide), 4th edition (2021); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders and osteoporosis monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: Weekly video therapy while away. Review on her return in about six weeks. [S]